BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/7/2018 2:16:27 AM | Browse: 773 | Download: 897
Publication Name World Journal of Clinical Oncology
Manuscript ID 38211
Country/Territory Switzerland
Received
2018-02-07 16:49
Peer-Review Started
2018-02-07 18:37
To Make the First Decision
2018-03-02 00:38
Return for Revision
2018-03-07 09:42
Revised
2018-04-18 13:42
Second Decision
2018-05-22 02:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-05-23 21:11
Articles in Press
2018-05-23 21:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-05-30 05:14
Publish the Manuscript Online
2018-06-07 02:16
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Epitranscriptomics of cancer
Manuscript Source Invited Manuscript
All Author List Marina Tusup, Thomas Kundig and Steve Pascolo
ORCID
Author(s) ORCID Number
Marina Tusup http://orcid.org/0000-0001-7746-1057
Thomas Kundig http://orcid.org/0000-0003-3863-8766
Steve Pascolo http://orcid.org/0000-0003-2946-5576
Funding Agency and Grant Number
Funding Agency Grant Number
University of Zurich: “URPP: Translational Cancer research”
“MERIT” project supported by the FP7 European Union’s Research and Innovation Funding program
Corresponding Author Steve Pascolo, PhD, Senior Scientist, Department of Dermatology, University Hospital of Zürich, Gloriastrasse 31, Zurich 8091, Switzerland. steve.pascolo@usz.ch
Key Words RNA modifications; N6-methyladenosine; 5-methylcytidine; 2’O-methylation or methylcytidine; Pseudouridine; Inosine
Core Tip The present manuscript reviews the current knowledge on RNA modifications in cancer. The potential impacts of N6-Methyladenosine, Pseudouridine, Inosine, 2’O-methylation or methylcytidine in cancer’s RNA is presented and discussed. The review also highlights the remaining questions and provides hints on research avenues and potential therapeutic applications, whereby modulating dynamic RNA modifications may be a new method to treat cancer.
Publish Date 2018-06-07 02:16
Citation Tusup M, Kundig T, Pascolo S. Epitranscriptomics of cancer. World J Clin Oncol 2018; 9(3): 42-55
URL http://www.wjgnet.com/2218-4333/full/v9/i3/42.htm
DOI http://dx.doi.org/10.5306/wjco.v9.i3.42
Full Article (PDF) WJCO-9-42.pdf
Full Article (Word) WJCO-9-42.doc
Manuscript File 38211-Review.docx
Answering Reviewers 38211-Answering reviewers.pdf
Audio Core Tip 38211-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 38211-Conflict-of-interest statement.pdf
Copyright License Agreement 38211-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 38211-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 38211-Language certificate.pdf
Supplementary Material 38211-Supplementary-Material-revision.pptx
Peer-review Report 38211-Peer-review(s).pdf
Scientific Editor Work List 38211-Scientific editor work list.pdf